The lipopolysaccharide of shigella bacteria as a virulence factor

Reviews of Infectious Diseases

Volumn 13, Issue , 1991, Pages S279-S284

  Lindberg, Alf A ^a   Kärnell, Anders ^a   Weintraub, Andrej ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE;

CONFERENCE PAPER; HOST RESISTANCE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; VIRULENCE;

CARBOHYDRATE SEQUENCE; DYSENTERY, BACILLARY; EPITOPES; HUMAN; LIPID A; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; SHIGELLA; SUPPORT, NON-U.S. GOV'T; VIRULENCE;

EID: 0025975993     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/13.Supplement_4.S279     Document Type: Article

References (30)

1. Rietschel ET, Brade L, Schade U, Zähringer U, Brade H Bacterial endotoxins: relation of chemical structure to biological activity. In: Majde JA, ed. Immunopharmacology of infectious diseases: vaccine adjuvants and modulators of non-specific resistance. New York: Alan R. Liss, 1987:75-89
2. Rietschel ET, Wollenweber H-W, Brade H, Zähringer U, Lindner B, Seydel U, Bradaczek H, Barnickel G, Labischinski H, Giesbrecht P. Structure and conformation of the lipid A component of lipopolysac- charides. In: Rietschel ET, ed. Handbook of endotoxin. Vol 1: chemistry of endotoxin. New York: Elsevier, 1984:187-220
3. Hase S, Rietschel ET. Isolation and analysis of the lipid A backbone. Lipid A structure of lipopolysaccharides from various bacterial groups. Eur J Biochem 1976;63:101-7
4. Lugowski C, Romanowska E. Chemical studies on Shigella sonnei lipid A. Eur J Biochem 1974;48:319-23
5. Bryn K, Rietschel ET. L-2-hydroxytetradecanoic acid as a constituent of Salmonella lipopolysaccharides (lipid A). Eur J Biochem 1978;86: 311-5
6. Brenner DJ. Characterization and clinical identification of Enterobacteriaceae by DNA-hybridization. Prog Clin Pathol 1978;7:71-117
7. Takada H, Kotani S, Tsujimoto M, Ogawa T, Takahashi I, Harada K, Katsukawa C, Tanaka S, Shiba T, Kusumoto S, Imoto M, Yoshimura H, Yamamoto M, Shimamoto T. Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs. Infect Immun 1985;48:219-27
8. Kumazawa Y, Nakatsuka M, Takimoto H, Furuya T, Nagumo T, Yamamoto A, Homma Y, Inada K, Yoshida M, Kiso M, Hasegawa A. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity. Infect Immun 1988;56:149-55
9. Rietschel ET, Brade L, Schade U, Seydel U, Zähringer U, Kusumoto S, Brade H. Bacterial endotoxins: properties and structure of biologically active domains. In: Schrinner E, Richmond M, Seibert G, Schwarz U, eds. Surface structures of microorganisms and their interactions with the mammalian host. Weinheim, Germany: Verlag Chemie, 1988;18:1-41
10. Jansson P-E, Lindberg AA, Lindberg B, Wollin R. Structural studies on the hexose region of the core in lipopolysaccharides from Enterobac- teriaceae. Eur J Biochem 1986;115:571-7
11. 1 core. Eur J Biochem 1978;88:267-73
12. Katzenellenbogen E, Romanowska E. Structural studies on Shigellaflexneri serotype 6 core region. Eur J Biochem 1980;113:205-11
13. Galanos C, Lüderitz O, Rietschel ET, Westphal O. Newer aspects of the chemistry and biology of bacterial lipopolysaccharides with special reference to their lipid A component. In: Goodwin TW, ed. International Review of Biochemistry, Vol. 14. Biochemistry of lipids II. Baltimore: University Park Press, 1977:239-335
14. Ewing WH, Lindberg AA. Serology of Shigella. In: Bergan T, ed. Methods in Microbiology. Vol 14. London: Academic Press, 1984;14: 113-42
15. Kenne L, Lindberg B. Bacterial polysaccharides. In: Aspinall GO, ed. Molecular biology. The polysaccharides. Vol. 2. New York: Academic Press, 1983:287-363
16. Okamura N, Nakaya R. Rough mutants of Shigella flexneri 2a that penetrate tissue culture cells but do not evoke keratoconjunctivitis in guinea pigs. Infect Immun 1977;17:4-8
17. Okamura N, Nagai T, Nakaya R, Kondo S, Murakami M, Hisatsune K. HeLa cell invasiveness and O antigen of Shigella flexneri as separate and prerequisite attributes of virulence to evoke keratoconjunctivitis in guinea pigs. Infect Immun 1983; 39:505-13
18. Grossman N, Leive L. Complement activation via the alternative path way by purified Salmonella lipopolysaccharide is affected by its structure but not its O-antigen length. J Immunol 1984;132:376-85
19. Liang-Takasaki C-J, Mäkelä PH, Leive L. Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J Immunol 1982; 128:1229-35
20. Grossman N, Svenson SB, Leive L, Lindberg AA. Salmonella O antigen-specific oligosaccharide-octyl conjugates activate complement via the alternative pathway at different rates depending on the structure of the O antigen. Mol Immunol 1990;27:859-65
21. Gemski P Jr, Sheahan DG, Washington O, Formal SB. Virulence of Shigella flexneri hybrids expressing Escherichia coli somatic antigens. Infect Immun 1972;6:104-11
22. Kenne L, Lindberg B, Madden JK, Lindberg AA, Gemski P Jr. Structural studies of the Escherichia coli O-antigen 25. Carbohydr Res 1983;122:249-56
23. Reske K, Jann K. The 08 antigen of Escherichia coli. Structure of the polysaccharide chain. Eur J Biochem 1972;31:320-8
24. Cheasty T, Rowe B. Antigenic relationships between the enteroinvasive Escherichia coli O antigens 028ac, 0112ac, 0124, 0136, 0143, 0144, 0152, and 0164 and Shigella O antigens. J Clin Microbiol 1983; 17:681-4
25. Mel D, Gangarosa EJ, Radovanovic ML, Arsic BL, Litvinjenko S. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains. Bull WHO 1971;45:457-64
26. Carlin NI, Lindberg AA. Monoclonal antibodies specific for Shigella flexneri lipopolysaccharides: clones binding to type IV, V and VI antigens, group 3, 4 antigen and an epitope common to all Shigella flexneri and Shigella dysenleriae type 1 strains. Infect Immun 1987;55:1412-20
27. Lindbeig AA, Ekwall E, Carlin NLA. Shigella flexneri O-antigen specific enzyme immunoassay: lipopolysaccharides and synthetic glycocon- jugates as antigens. Serodiagnosis and Immunotherapy in Infectious Disease 1988;2:63-78
28. Ekwall E, Cam PD, Chan N, Phu LK, Trach DD, Lindbeig AA. Shigella flexneri O-antigen specific enzyme immunoassay: a prospective study of class-specific antibody titers against lipopolysaccharide antigens in Vietnamese children and adults with serotype lb or 2a dysentery. Serodiagnosis Immunotherapy in Infectious Disease 1988;2:171-82
29. Formal SB, Baron LS, Kopecko DJ, Washington O, Powell C, Life CA. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form 1 antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun 1981;34:746-50
30. Sturm S, Timmis KN. Cloning of the rfb gene region of Shigella dysenteriae 1 and construction of an rfb-rfp gene cassette for the development of lipopolysaccharide-based live anti-dysentery vaccines. Microb Pathog 1986;1:289-97